# 📊 Novartis Financial Analysis (2019-2023); Benchmarking with AstraZeneca & Roche  

## 📌 Overview  
This repository presents a **detailed financial analysis of Novartis** over a five-year period (2019-2023), benchmarking its performance against AstraZeneca and Roche. This project was conducted for the **Accounting, Finance & Control Course** at **Politecnico di Milano** during the **first semester of the 2024/2025 academic year (A.Y.)**.

## 🔍 Key Areas of Analysis  
- **Context Analysis**: Industry trends, market size, and competitive positioning.  
- **Segmental Analysis**: Regional performance, therapeutic areas, and revenue breakdown.  
- **Financial Analysis**: Profitability, return on equity, EBITDA margins, and debt structure.  
- **Value Creation**: Sustainability efforts, R&D strategy, and business model transformation.  

## 📁 Contents  
- **📄 Report:** Full financial analysis of Novartis, AstraZeneca, and Roche.  
- **📊 Data & Visualizations:** Graphs and financial models used in the study.  
- **📑 Supporting Annexes:** Detailed segmental and benchmarking data.

## 📖 Key Findings  
✅ Novartis has demonstrated **consistent revenue growth** but faced short-term profitability fluctuations due to strategic restructuring.  
✅ The company’s **shift towards innovative medicines** (vs. generics) has improved long-term financial sustainability.  
✅ R&D investments have increased steadily, aligning with **a focus on high-margin therapeutic areas**.  
✅ AstraZeneca exhibited **higher revenue growth**, while Roche maintained **higher profitability margins** due to its strong diagnostics division.  

## 📌 Project Details  
- **Course**: Accounting, Finance & Control  
- **Institution**: Politecnico di Milano  
- **Academic Year**: 2024/2025 (First Semester)  
- **Authors**: Schuyler Rideout, Rodrigo Neves Carvalho Bastos, Beatriz Rocha Freitas Brandão, Mahan Pourhosseini, Emil Øhlenschlæger, Gonçalo Nuno Noronha da Câmara de Santa Clara Gomes  

## 🔗 References  
- **Novartis Annual Reports**: [novartis.com](https://www.novartis.com/investors/financial-data/annual-results)  
- **AstraZeneca Financials**: [astrazeneca.com](https://www.astrazeneca.com/investor-relations/annual-reports.html)  
- **Roche Financials**: [roche.com](https://www.roche.com/investors/reports)  
